Nissay Asset Management Corp Biomarin Pharmaceutical Inc Transaction History

Nissay Asset Management Corp

  • $16.7 Billion
  • Q2 2025

A detailed history of Nissay Asset Management Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 24,367 shares of BMRN stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,367
Previous 23,536 3.53%
Holding current value
$1.26 Million
Previous $1.66 Million 19.48%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$54.08 - $68.32 $44,940 - $56,773
831 Added 3.53%
24,367 $1.34 Million
Q1 2025

May 15, 2025
BUY
$61.25 - $72.83 $17,333 - $20,610
283 Added 1.22%
23,536 $1.66 Million
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $20,684 - $23,543
334 Added 1.46%
23,253 $1.53 Million
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $48,244 - $65,594
699 Added 3.15%
22,919 $1.61 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $63,191 - $78,294
849 Added 3.97%
22,220 $1.83 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $35,870 - $42,372
428 Added 2.04%
21,371 $1.87 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $55,564 - $71,813
729 Added 3.61%
20,943 $2.02 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $60,399 - $67,080
710 Added 3.64%
20,214 $1.79 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $26,697 - $30,892
-308 Reduced 1.55%
19,504 $1.69 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $63,348 - $84,668
-722 Reduced 3.52%
19,812 $1.93 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $3,722 - $4,996
-46 Reduced 0.22%
20,534 $2.13 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $74,847 - $88,312
911 Added 4.63%
20,580 $1.75 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $3,931 - $4,776
-55 Reduced 0.28%
19,669 $1.63 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $35,357 - $44,120
476 Added 2.47%
19,724 $1.52 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $41,741 - $53,235
582 Added 3.12%
19,248 $1.7 Million
Q3 2021

Nov 10, 2021
BUY
$74.77 - $85.47 $62,806 - $71,794
840 Added 4.71%
18,666 $1.44 Million
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $25,220 - $28,319
334 Added 1.91%
17,826 $1.49 Million
Q1 2021

May 11, 2021
SELL
$74.73 - $90.69 $4.26 Million - $5.16 Million
-56,945 Reduced 76.5%
17,492 $1.32 Million
Q4 2020

Feb 08, 2021
SELL
$72.61 - $90.2 $933,401 - $1.16 Million
-12,855 Reduced 14.73%
74,437 $6.53 Million
Q3 2020

Oct 20, 2020
BUY
$71.87 - $131.03 $817,952 - $1.49 Million
11,381 Added 14.99%
87,292 $6.64 Million
Q2 2020

Jul 27, 2020
BUY
$79.55 - $124.22 $1.4 Million - $2.18 Million
17,557 Added 30.09%
75,911 $9.36 Million
Q1 2020

May 05, 2020
BUY
$71.37 - $96.85 $3.11 Million - $4.22 Million
43,537 Added 293.83%
58,354 $4.93 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $28,728 - $38,607
447 Added 3.11%
14,817 $1.25 Million
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $50,415 - $63,662
748 Added 5.49%
14,370 $969,000
Q2 2019

Aug 07, 2019
SELL
$80.35 - $93.9 $26,997 - $31,550
-336 Reduced 2.41%
13,622 $1.17 Million
Q1 2019

May 03, 2019
BUY
$84.2 - $98.62 $69,633 - $81,558
827 Added 6.3%
13,958 $1.24 Million
Q4 2018

Feb 06, 2019
BUY
$80.14 - $106.07 $47,202 - $62,475
589 Added 4.7%
13,131 $1.12 Million
Q3 2018

Oct 30, 2018
BUY
$93.92 - $105.72 $43,578 - $49,054
464 Added 3.84%
12,542 $1.22 Million
Q2 2018

Aug 08, 2018
BUY
$76.01 - $99.03 $42,261 - $55,060
556 Added 4.83%
12,078 $1.14 Million
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $13,281 - $15,839
171 Added 1.51%
11,522 $934,000
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $916,706 - $1.08 Million
11,351
11,351 $1.01 Million

Others Institutions Holding BMRN

# of Institutions
693
Shares Held
187M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $9.65B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email